SynthesisFrontiers in oncology2022

Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.